Orthopediatrics Historical Income Statement

KIDS Stock

USD 25.98 0.59 2.32%

Historical analysis of Orthopediatrics Corp income statement accounts such as Selling And Marketing Expenses of 31.9 M can show how well Orthopediatrics Corp performed in making a profits. Evaluating Orthopediatrics Corp income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Orthopediatrics Corp's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Orthopediatrics Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Orthopediatrics Corp is a good buy for the upcoming year.

Net Income Gross Profit

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Orthopediatrics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy Orthopediatrics Stock please use our How to Invest in Orthopediatrics Corp guide.

About Orthopediatrics Income Statement Analysis

Orthopediatrics Corp Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Orthopediatrics Corp shareholders. The income statement also shows Orthopediatrics investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Orthopediatrics Corp Income Statement Chart

At this time, Orthopediatrics Corp's Depreciation And Amortization is comparatively stable compared to the past year. Selling General Administrative is likely to gain to about 79.2 M in 2024, whereas Interest Expense is likely to drop slightly above 188.1 K in 2024.

Selling General Administrative Selling And Marketing Expenses Total Revenue Gross Profit Extraordinary Items Net Interest Income

Total Revenue

Total revenue comprises all receipts Orthopediatrics Corp generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Orthopediatrics Corp minus its cost of goods sold. It is profit before Orthopediatrics Corp operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Net Interest Income

The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.

Most accounts from Orthopediatrics Corp's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Orthopediatrics Corp current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Orthopediatrics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy Orthopediatrics Stock please use our How to Invest in Orthopediatrics Corp guide.At this time, Orthopediatrics Corp's Depreciation And Amortization is comparatively stable compared to the past year. Selling General Administrative is likely to gain to about 79.2 M in 2024, whereas Interest Expense is likely to drop slightly above 188.1 K in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	2.2M	2.4M	198K	188.1K
Depreciation And Amortization	10.7M	13.1M	17.4M	18.3M

Interest Expense Depreciation And Amortization

Orthopediatrics Corp income statement Correlations

	Discontinued Operations	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Interest Income	Extraordinary Items	Net Interest Income	Reconciled Depreciation	Non Operating Income Net Other	Tax Provision	Non Recurring
Discontinued Operations		-0.57	0.15	-0.62	-0.75	-0.7	-0.71	-0.69	0.56	0.3	0.54	-0.72	0.29	-0.67	-0.69	0.37	-0.18	0.34	0.42	-0.8	0.99	-0.49	-0.56	-0.36	0.19	0.44
Depreciation And Amortization	-0.57		-0.57	1.0	0.86	0.87	0.87	0.88	-0.97	-0.43	-0.86	0.84	-0.38	0.87	0.88	-0.52	0.5	-0.42	-0.67	0.73	-0.54	0.87	0.92	0.89	-0.2	-0.79
Interest Expense	0.15	-0.57		-0.55	-0.29	-0.35	-0.34	-0.34	0.44	0.1	0.27	-0.3	-0.17	-0.39	-0.33	0.09	-0.37	0.05	0.25	-0.03	0.09	-0.77	-0.4	-0.7	-0.22	0.44
Selling General Administrative	-0.62	1.0	-0.55		0.88	0.89	0.89	0.89	-0.97	-0.43	-0.87	0.87	-0.38	0.88	0.89	-0.52	0.5	-0.43	-0.67	0.76	-0.59	0.87	0.92	0.89	-0.21	-0.77
Selling And Marketing Expenses	-0.75	0.86	-0.29	0.88		0.99	0.99	0.99	-0.88	-0.35	-0.8	0.98	-0.38	0.98	0.99	-0.44	0.45	-0.36	-0.68	0.94	-0.75	0.69	0.94	0.69	-0.35	-0.72
Total Revenue	-0.7	0.87	-0.35	0.89	0.99		1.0	1.0	-0.87	-0.3	-0.78	0.98	-0.32	1.0	1.0	-0.39	0.5	-0.3	-0.68	0.91	-0.7	0.71	0.96	0.74	-0.36	-0.71
Gross Profit	-0.71	0.87	-0.34	0.89	0.99	1.0		1.0	-0.88	-0.32	-0.79	0.99	-0.34	0.99	1.0	-0.41	0.49	-0.32	-0.68	0.92	-0.7	0.71	0.96	0.73	-0.35	-0.71
Other Operating Expenses	-0.69	0.88	-0.34	0.89	0.99	1.0	1.0		-0.89	-0.33	-0.81	0.98	-0.36	0.99	1.0	-0.42	0.5	-0.33	-0.7	0.91	-0.68	0.71	0.97	0.74	-0.36	-0.72
Operating Income	0.56	-0.97	0.44	-0.97	-0.88	-0.87	-0.88	-0.89		0.54	0.96	-0.85	0.58	-0.86	-0.9	0.64	-0.43	0.51	0.74	-0.77	0.54	-0.78	-0.94	-0.81	0.24	0.73
Net Income From Continuing Ops	0.3	-0.43	0.1	-0.43	-0.35	-0.3	-0.32	-0.33	0.54		0.69	-0.34	0.78	-0.24	-0.35	0.99	0.51	0.99	0.07	-0.45	0.29	-0.37	-0.36	-0.09	-0.53	0.21
Ebit	0.54	-0.86	0.27	-0.87	-0.8	-0.78	-0.79	-0.81	0.96	0.69		-0.77	0.79	-0.75	-0.82	0.79	-0.23	0.67	0.7	-0.76	0.53	-0.63	-0.86	-0.63	0.17	0.59
Research Development	-0.72	0.84	-0.3	0.87	0.98	0.98	0.99	0.98	-0.85	-0.34	-0.77		-0.35	0.97	0.98	-0.42	0.45	-0.35	-0.62	0.93	-0.72	0.71	0.92	0.72	-0.32	-0.61
Ebitda	0.29	-0.38	-0.17	-0.38	-0.38	-0.32	-0.34	-0.36	0.58	0.78	0.79	-0.35		-0.26	-0.39	0.84	0.21	0.75	0.45	-0.46	0.29	-0.12	-0.41	-0.07	0.03	0.11
Cost Of Revenue	-0.67	0.87	-0.39	0.88	0.98	1.0	0.99	0.99	-0.86	-0.24	-0.75	0.97	-0.26		0.99	-0.33	0.56	-0.24	-0.69	0.88	-0.66	0.72	0.96	0.77	-0.38	-0.73
Total Operating Expenses	-0.69	0.88	-0.33	0.89	0.99	1.0	1.0	1.0	-0.9	-0.35	-0.82	0.98	-0.39	0.99		-0.44	0.48	-0.35	-0.7	0.92	-0.68	0.7	0.97	0.73	-0.35	-0.71
Income Before Tax	0.37	-0.52	0.09	-0.52	-0.44	-0.39	-0.41	-0.42	0.64	0.99	0.79	-0.42	0.84	-0.33	-0.44		0.4	0.97	0.21	-0.53	0.36	-0.4	-0.45	-0.18	-0.39	0.29
Total Other Income Expense Net	-0.18	0.5	-0.37	0.5	0.45	0.5	0.49	0.5	-0.43	0.51	-0.23	0.45	0.21	0.56	0.48	0.4		0.54	-0.69	0.22	-0.18	0.41	0.53	0.73	-0.79	-0.44
Net Income	0.34	-0.42	0.05	-0.43	-0.36	-0.3	-0.32	-0.33	0.51	0.99	0.67	-0.35	0.75	-0.24	-0.35	0.97	0.54		0.01	-0.48	0.33	-0.34	-0.33	-0.08	-0.53	0.19
Income Tax Expense	0.42	-0.67	0.25	-0.67	-0.68	-0.68	-0.68	-0.7	0.74	0.07	0.7	-0.62	0.45	-0.69	-0.7	0.21	-0.69	0.01		-0.52	0.41	-0.47	-0.74	-0.6	0.68	0.61
Interest Income	-0.8	0.73	-0.03	0.76	0.94	0.91	0.92	0.91	-0.77	-0.45	-0.76	0.93	-0.46	0.88	0.92	-0.53	0.22	-0.48	-0.52		-0.8	0.52	0.83	0.48	-0.27	-0.58
Extraordinary Items	0.99	-0.54	0.09	-0.59	-0.75	-0.7	-0.7	-0.68	0.54	0.29	0.53	-0.72	0.29	-0.66	-0.68	0.36	-0.18	0.33	0.41	-0.8		-0.46	-0.55	-0.33	0.21	0.42
Net Interest Income	-0.49	0.87	-0.77	0.87	0.69	0.71	0.71	0.71	-0.78	-0.37	-0.63	0.71	-0.12	0.72	0.7	-0.4	0.41	-0.34	-0.47	0.52	-0.46		0.72	0.86	0.08	-0.67
Reconciled Depreciation	-0.56	0.92	-0.4	0.92	0.94	0.96	0.96	0.97	-0.94	-0.36	-0.86	0.92	-0.41	0.96	0.97	-0.45	0.53	-0.33	-0.74	0.83	-0.55	0.72		0.79	-0.37	-0.78
Non Operating Income Net Other	-0.36	0.89	-0.7	0.89	0.69	0.74	0.73	0.74	-0.81	-0.09	-0.63	0.72	-0.07	0.77	0.73	-0.18	0.73	-0.08	-0.6	0.48	-0.33	0.86	0.79		-0.3	-0.63
Tax Provision	0.19	-0.2	-0.22	-0.21	-0.35	-0.36	-0.35	-0.36	0.24	-0.53	0.17	-0.32	0.03	-0.38	-0.35	-0.39	-0.79	-0.53	0.68	-0.27	0.21	0.08	-0.37	-0.3		0.22
Non Recurring	0.44	-0.79	0.44	-0.77	-0.72	-0.71	-0.71	-0.72	0.73	0.21	0.59	-0.61	0.11	-0.73	-0.71	0.29	-0.44	0.19	0.61	-0.58	0.42	-0.67	-0.78	-0.63	0.22

Click cells to compare fundamentals

Orthopediatrics Corp Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Orthopediatrics Stock Analysis

When running Orthopediatrics Corp's price analysis, check to measure Orthopediatrics Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthopediatrics Corp is operating at the current time. Most of Orthopediatrics Corp's value examination focuses on studying past and present price action to predict the probability of Orthopediatrics Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthopediatrics Corp's price. Additionally, you may evaluate how the addition of Orthopediatrics Corp to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Orthopediatrics Historical Income Statement

About Orthopediatrics Income Statement Analysis

Orthopediatrics Corp Income Statement Chart

Total Revenue

Gross Profit

Net Interest Income

Orthopediatrics Corp income statement Correlations

Orthopediatrics Corp Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Orthopediatrics Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Selling General Administrative	+ 1.0	Depreciation And Amortization
Gross Profit	+ 1.0	Total Revenue
Other Operating Expenses	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue
Total Operating Expenses	+ 1.0	Total Revenue
Other Operating Expenses	+ 1.0	Gross Profit

Operating Income	- 0.97	Selling General Administrative
Operating Income	- 0.97	Depreciation And Amortization
Reconciled Depreciation	- 0.94	Operating Income
Total Operating Expenses	- 0.9	Operating Income
Operating Income	- 0.89	Other Operating Expenses
Operating Income	- 0.88	Gross Profit